Bagley Amends ClearOne (CLRO) Stake Filing
Ticker: CLRO · Form: SC 13D/A · Filed: Mar 18, 2024 · CIK: 840715
Sentiment: neutral
Topics: 13D-filing, shareholder-activity, amendment
Related Tickers: CLRO
TL;DR
Bagley updated his CLRO filing, watch for changes in his stake.
AI Summary
E. Bryan Bagley filed an amendment (No. 1) to Schedule 13D on March 13, 2024, regarding his beneficial ownership of ClearOne, Inc. (CLRO). The filing indicates a change in the reporting person's holdings, though specific new ownership percentages or dollar amounts are not detailed in this excerpt. This amendment updates previous filings concerning Bagley's stake in the company.
Why It Matters
Amendments to Schedule 13D filings signal potential shifts in significant shareholder positions, which can influence stock price and corporate strategy.
Risk Assessment
Risk Level: medium — Schedule 13D filings often precede significant corporate actions or shifts in control, introducing potential volatility.
Key Players & Entities
- E. Bryan Bagley (person) — Reporting Person
- ClearOne, Inc. (company) — Issuer
- CLRO (company) — Ticker Symbol
FAQ
What is the purpose of this Schedule 13D/A filing?
This filing is an amendment (No. 1) to a previously filed Schedule 13D, updating information regarding the beneficial ownership of ClearOne, Inc. by E. Bryan Bagley.
Who is the reporting person in this filing?
The reporting person is E. Bryan Bagley, with a mailing address at 1470 Arlington Drive, Salt Lake City, Utah 84103.
What is the CUSIP number for ClearOne, Inc. common stock?
The CUSIP number for ClearOne, Inc. common stock is 18506U104.
When was the event requiring this filing amendment?
The date of the event which requires filing of this amendment is March 13, 2024.
What is the primary business of ClearOne, Inc. according to the filing?
ClearOne, Inc. is in the TELEPHONE & TELEGRAPH APPARATUS industry, SIC code 3661.
Filing Stats: 994 words · 4 min read · ~3 pages · Grade level 8 · Accepted 2024-03-18 16:45:12
Key Financial Figures
- $2.10 — Mr. Bagley's IRA sold 21,952 shares for $2.10 per share and 32,918 shares for $2.18 p
- $2.18 — r $2.10 per share and 32,918 shares for $2.18 per share. On March 13, 2024, M r. Ba
- $2.17 — reviously beneficially owned by them at $2.17 per share and $2.19 per share, respecti
- $2.19 — ly owned by them at $2.17 per share and $2.19 per share, respectively. On March 13,
- $2 — 222,373 shares for an average price of $2. 1344 per share . On March 14, 2024,
Filing Documents
- MainDocument.htm (SC 13D/A) — 66KB
- 0001753926-24-000552.txt ( ) — 67KB
Security and Issuer
Item 1. Security and Issuer This Amendment No. 11 (this "Amendment") to the Statement on Schedule 13D filed on September 18, 2020 (the "Schedule 13D") relates to the shares of common stock, par value $.001 per share (the "Common Stock"), of ClearOne , Inc., a Delaware corporation (the "Company"). The Company's principal executive offices are located at 5225 Wiley Post Way, Suite 500, Salt Lake City, Utah 84116. Except as amended by this Amendment, there are no changes to the disclosures in the Schedule 13D.
of the Schedule 13D is hereby amended and supplemented to read as follows
Item 5 of the Schedule 13D is hereby amended and supplemented to read as follows:
Interest in Securities of the Company
Item 5. Interest in Securities of the Company (a) In the aggregate, as of March 14, 2024, E. Bryan Bagley beneficially owns 1,061,784 shares of the Issuer's Common Stock, representing approximately 4.4% of such class of securities, including 134,866 shares directly beneficially owned by Mr. Bagley and 926,918 indirectly beneficially owned by Mr. Bagley through a revocable trust. This percentage is calculated based upon the 23,960,684 issued and outstanding shares of common stock as of November 7, 2023 as reported in the Company's quarterly report on Form 10-Q for the quarter ended September 30, 2023 and assumes the exercise of all 106,818 warrants beneficially owned by the reporting person . (b) Mr. Bagley has the sole power to vote or to direct the vote, and the sole power to dispose or to direct the disposition of, 134,866 shares of the Company's common stock, including warrants to purchase 56,818 shares of the Company's common stock, and shared power to vote or direct the vote, and shared power to dispose or to direct the disposition of, 926,918 shares of the Company's common stock, including warrants to purchase 50,000 shares of the Company's common stock . (c) Subsequent to the filing of the Schedule 13D, the Reporting Persons engaged in the following transactions with respect to the Company 's securities within the last 60 days: On March 13, 2024, Mr. Bagley's IRA sold 21,952 shares for $2.10 per share and 32,918 shares for $2.18 per share. On March 13, 2024, M r. Bagley's two children each sold all 5,631 shares previously beneficially owned by them at $2.17 per share and $2.19 per share, respectively. On March 13, 2024, Mr. Bagley's revocable trust sold 222,373 shares for an average price of $2. 1344 per share . On March 14, 2024, Mr. Bagley's revocable trust sold 7,700 shares for an average price of $2. 01 per share. (d) No person, other than M r. Bagley and his revocable trust , has the power to direct the receipt of dividends on and the pro